Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Disc Goes Public As Gemini Downshifts F
Blood-based cancer diagnostics firm VolitionRx Ltd. has launched a new colorectal cancer blood-screening test for use with fecal immunochemical tests (FITs). Nu.Q is an ELISA test based on techn
IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Zephyrus Biosciences Inc. Bio-Techne acquired private research tools company Zephyrus Biosciences Inc. Zephyrus will be rolled up into Bi